Urine Protein News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Urine protein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Urine Protein Today - Breaking & Trending Today

CSL Vifor and Travere Therapeutics announce sparsentan receives positive CHMP opinion for the treatment of IgA nephropathy

CSL Vifor and Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that the European Medicines Agency's (EMA) CHMP has recommended approval of sparsentan for the treatment of adults with primary IgAN with a urine protein excretion >1.0 g/day (or urine protein-to-creatinine ratio ≥0.75 g/g). IgAN is a rare kidney disorder and a leading cause of kidney failure. The CHMP opinion provides the basis for the European Commission's final decision regarding CMA for sparsentan. If approved in Europe ....

New Zealand , Emmanuelle Lecomte Brisset , Fresenius Medical Care , European Commission , Vifor International , Head Of Global Regulatory Affairs , Drug Administration , European Union , Senior Vice President , Global Regulatory Affairs , Travere Therapeutics , Marketing Authorization Application , Orphan Medicinal Product Designation , Vifor Fresenius Medical Care Renal Pharma , Iga Nephropathy , Csl Vifor , European Commission , Treatment Options , Kidney Failure , Kidney Disorder , European Medicines Agency , Treatment Option , Kidney Function , Urine Protein ,

Increased awareness boosts the diabetes diagnostic market

India is called the 'diabetes capital' of the world and the burden is increasing day by day, especially in urban areas. As per reports, 26.1 per cent urban residents aged 60 years or more are diabetic and 9.3 per cent senior citizens living in India's rural areas are also diabetic. Among Indians over 45 years of age, 11.5 per cent were diagnosed with high blood sugar levels. India Diabetes Market size is expected to grow at an average CAGR of 6.5 per cent during 2016-2023. Global market for Diabetes Diagnostics estimated at $26.5 billion in 2020, it’s projected to reach $42.4 billion by 2026, growing at a CAGR of 8.1 per cent. Test Strip is projected to record a 8.3 per cent CAGR to reach $11.3 billion by 2026. Same rate will be applicable for India too. Increasing frequency and convenience in testing give a good boost to the diabetes diagnostic segment. ....

Thomas John , Asia Pacific , Diabetes Market , Blood Glucose Monitoring Devices , Testing Devices , Continuous Glucose Monitoring , Glucose Hexokinase , Indian Hba , Renal Function , Renal Function Test , Urine Protein , Creatinine Clearance , Blood Tests , Serum Creatinine , Glucose Monitoring , Prime Minister , Managing Director , Agappe Diagnostics , Thomas John , Agappe Diagnostics ,

Detailed text transcripts for TV channel - FOXNEWS - 20140216:15:34:00

Now we have come back to a drug we discarded and it s having great uses because it cuts down blood flow. we use bone marrow transplants and stem cells where we wipe out the bone marrow, we can preplace it with a person s own cells that have been cleansed of the cancer cells. it made a dramatic change in the disease. it is no longer the uniform killer. how do you know you have it? what you would do is get the urine protein, meaning you get your urine and blood and you get the urine and the blood test and you look for the proteins that mark is talking about. the reason why i jumped in, i want to make sure people know about the international myeloma foundation. 1-800-452-2873. i will post this on my facebook. this is the foundation that reaches out to a lot of people. ....

Bone Marrow , Stem Cells , Blood Flow , Cancer Cells , Uniform Killer , Urine Protein , Blood Test , 1 800 452 2873 ,